QNTP.F Stock Overview

An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally. More details

QNTP.F fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 4.8% below our estimate of its fair value

Revenue is forecast to grow 46.08% per year

Revenue grew by 52.8% over the past year

Risk Analysis

Shares are highly illiquid

Currently unprofitable and not forecast to become profitable over the next 3 years

XtalPi Holdings Limited Competitors

Sotera Health

NasdaqGS:SHC

US$3.2b

Tempus AI

NasdaqGS:TEM

US$9.2b

Bruker

NasdaqGS:BRKR

US$5.9b

Azenta

NasdaqGS:AZTA

US$1.2b

Price History & Performance

Summary of share price highs, lows and changes for XtalPi Holdings
Historical stock prices
Current Share Price	HK$1.00
52 Week High	HK$1.00
52 Week Low	HK$1.00
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	QNTP.F	US Life Sciences	US Market
7D	0%	3.2%	4.8%
1Y	n/a	-26.4%	7.8%

Return vs Industry: Insufficient data to determine how QNTP.F performed against the US Life Sciences industry.

Return vs Market: Insufficient data to determine how QNTP.F performed against the US Market.

Price Volatility

Is QNTP.F's price volatile compared to industry and market?
QNTP.F volatility
QNTP.F Average Weekly Movement	n/a
Life Sciences Industry Average Movement	10.6%
Market Average Movement	7.8%
10% most volatile stocks in US Market	16.5%
10% least volatile stocks in US Market	4.1%

Stable Share Price: QNTP.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine QNTP.F's volatility change over the past year.

Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

About the Company

Founded	Employees	CEO	Website
2015	809	Jian Ma	www.xtalpi.com

XtalPi Holdings Limited, an investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally. The company offers XMolGen, an AI small molecule drug discovery smart computation platform; XtalFold, an antibody-antigen complex structure prediction platform which predicts the antibody-antigen complex structure and identifies key interaction sites; and Xtalgazer, a new generation of drug crystallization research and development platform which predict the physicochemical properties, crystal structure, and stability relationship of compound molecules based on hundreds of thousands of crystallization data accumulated by physical models combined with AI algorithms. It also provides automated chemical synthesis services; and Al+robotics laboratory intelligent automation solutions.

XtalPi Holdings Limited Fundamentals Summary

How do XtalPi Holdings's earnings and revenue compare to its market cap?
QNTP.F fundamental statistics
Market cap	US$2.56b
Earnings (TTM)	-US$208.11m
Revenue (TTM)	US$36.56m

70.0x

P/S Ratio

-12.3x

P/E Ratio

Is QNTP.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QNTP.F income statement (TTM)
Revenue	CN¥266.43m
Cost of Revenue	CN¥143.01m
Gross Profit	CN¥123.43m
Other Expenses	CN¥1.64b
Earnings	-CN¥1.52b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.38
Gross Margin	46.33%
Net Profit Margin	-569.23%
Debt/Equity Ratio	1.3%

How did QNTP.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/26 06:57
End of Day Share Price	2025/04/09 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

XtalPi Holdings Limited is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yu Wu	CMB International Securities Limited
Yue-Kwong Lui	Jefferies LLC
Cui Cui	Jefferies LLC